FTC Faces Uphill Battle In AndroGel Pay-For-Delay Suit

While the Federal Trade Commission won a court order requiring AbbVie to turn over documents in its AndroGel patent settlement the judge dismissed a big chunk of the agency’s complaint.

More from Legal & IP

More from Pink Sheet